BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 10796908)

  • 41. [Diagnostic value of secretin injections in dynamic MR pancreatography].
    Petersein J; Reisinger W; Hamm B
    Rofo; 2002 Apr; 174(4):437-43. PubMed ID: 11960406
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relation of exocrine pancreatic function to the diameter of the pancreatic and common bile ducts.
    Nakajima S; Nakano S; Horiguchi Y; Suzuko T
    Am J Gastroenterol; 1976 Feb; 65(2):142-7. PubMed ID: 1274941
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pancreatic function testing is best determined by the extended endoscopic collection technique.
    Moolsintong P; Burton FR
    Pancreas; 2008 Nov; 37(4):418-21. PubMed ID: 18953255
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlation between secretin-enhanced MRCP findings and histopathologic severity of chronic pancreatitis in a cat model.
    Zhang TT; Wang L; Wang DB; Huang ZJ; Li YH; Lu JP
    Pancreatology; 2013; 13(5):491-7. PubMed ID: 24075513
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pancreas divisum and "santorinicele": diagnosis with dynamic MR cholangiopancreatography with secretin stimulation.
    Manfredi R; Costamagna G; Brizi MG; Spina S; Maresca G; Vecchioli A; Mutignani M; Marano P
    Radiology; 2000 Nov; 217(2):403-8. PubMed ID: 11058635
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationship between pancreatic exocrine function and ductal morphology in chronic pancreatitis.
    Braganza JM; Hunt LP; Warwick F
    Gastroenterology; 1982 Jun; 82(6):1341-7. PubMed ID: 7067955
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exocrine pancreatic function in correlation to ductal and parenchymal morphology in chronic pancreatitis.
    Malfertheiner P; Büchler M; Stanescu A; Ditschuneit H
    Hepatogastroenterology; 1986 Jun; 33(3):110-4. PubMed ID: 3744281
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pancreatic ductal abnormalities documented by secretin-enhanced MRCP in asymptomatic subjects with chronic pancreatic hyperenzymemia.
    Testoni PA; Mariani A; Curioni S; Giussani A; Masci E
    Am J Gastroenterol; 2009 Jul; 104(7):1780-6. PubMed ID: 19436288
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exocrine pancreatic hypersecretion in Brazilian alcoholics.
    Neves MM; Borges DR; Vilela MP
    Am J Gastroenterol; 1983 Aug; 78(8):513-6. PubMed ID: 6881118
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MR pancreatography: technique and applications.
    Takehara Y
    Top Magn Reson Imaging; 1996 Oct; 8(5):290-301. PubMed ID: 8914227
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship of pancreatic function and glucose tolerance to the morphology of the pancreatic ductal system as revealed by ERCP.
    Lehtola J; Karvonen AL; Lähde S; Tunturi-Hihnala H
    Hepatogastroenterology; 1984 Jun; 31(3):135-9. PubMed ID: 6469204
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Some aspects of pancreas exocrine secretion (our experience with the maximal secretin test].
    Bordalo O
    Cah Med; 1970 Oct; 11(12):1047-53. PubMed ID: 5485216
    [No Abstract]   [Full Text] [Related]  

  • 53. The effect of prior sphincterotomy on the secretin-stimulated magnetic resonance cholangiopancreatography (s-MRCP).
    Chopra A; Alkaade S; Balci NC; Burton F
    Acad Radiol; 2009 Nov; 16(11):1381-5. PubMed ID: 19683944
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intraductal secretin test is as useful as duodenal secretin test in assessing exocrine pancreatic function.
    Ochi K; Harada H; Mizushima T; Tanaka J; Matsumoto S
    Dig Dis Sci; 1997 Mar; 42(3):492-6. PubMed ID: 9073129
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The efficiency of endoscopic pancreatic function testing is optimized using duodenal aspirates at 30 and 45 minutes after intravenous secretin.
    Stevens T; Conwell DL; Zuccaro G; Lewis SA; Love TE
    Am J Gastroenterol; 2007 Feb; 102(2):297-301. PubMed ID: 17100964
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum immunoreactive trypsin after secretin stimulation in chronic pancreatitis.
    Vezzadini P; Gullo L; Sternini C; Bonora G; Ferri GL; Labò G
    Scand J Gastroenterol Suppl; 1980; 62():29-34. PubMed ID: 6935752
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Secretin-stimulated MR cholangio-pancreatography in the evaluation of asymptomatic patients with non-specific pancreatic hyperenzymemia.
    Donati F; Boraschi P; Gigoni R; Salemi S; Faggioni L; Bertucci C; Cecchi C; Bartolozzi C; Falaschi F
    Eur J Radiol; 2010 Aug; 75(2):e38-44. PubMed ID: 20005059
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pancreatic exocrine and endocrine responses in chronic pancreatitis.
    Anagnostides AA; Cox TM; Adrian TE; Christofides ND; Maton PN; Bloom SR; Chadwick VS
    Am J Gastroenterol; 1984 Mar; 79(3):206-12. PubMed ID: 6367435
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Abnormal duodenal [HCO3-] following secretin stimulation develops sooner than endocrine insufficiency in minimal change chronic pancreatitis.
    Pelley JR; Gordon SR; Gardner TB
    Pancreas; 2012 Apr; 41(3):481-4. PubMed ID: 22228105
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnosis of early-stage chronic pancreatitis by secretin-enhanced magnetic resonance cholangiopancreatography.
    Czakó L
    J Gastroenterol; 2007 Jan; 42 Suppl 17():113-7. PubMed ID: 17238039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.